Haemonetics
257 hedge funds and large institutions have $2.65B invested in Haemonetics in 2021 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 88 increasing their positions, 81 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.55% less ownership
Funds ownership: 99.55% → 97.99% (-1.6%)
26% less capital invested
Capital invested by funds: $3.58B → $2.65B (-$926M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
257
Holding in Top 10
1
Calls
$15.8M
Puts
$3.77M
Top Buyers
| 1 | +$48.6M | |
| 2 | +$44M | |
| 3 | +$20.5M | |
| 4 |
Morgan Stanley
New York
|
+$12.9M |
| 5 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
+$9.63M |
Top Sellers
| 1 | -$40.4M | |
| 2 | -$31.8M | |
| 3 | -$24.9M | |
| 4 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
-$21.1M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$18.8M |